10/07/2025
Spravato® (esketamine nasal spray) is FDA-approved for adults with treatment-resistant depression, and at Vital IV Infusions, most insurance plans cover this fast-acting treatment.
Each dose is therapeutic, carefully monitored, and administered in a safe, supportive environment to ensure patients get the full benefit.
📊 We track progress using both clinical assessments and patient feedback, so every patient’s experience is personalized, meaningful, and impactful.
Spravato® offers hope when traditional antidepressants haven’t worked, helping reduce depressive symptoms and suicidal thoughts in a structured, guided care setting.
Call now for more information!